Aethlon Medical Inc (AEMD) stock
AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)
Close on Nov 18, 2026Market cap $3.63MP/E –Yield –
Aethlon Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Aethlon Medical's operating cash flow for the twelve months ending Mar 31, 2026 was -$7.00M. For fiscal 2026 it was -$7.00M. The highest annual figure on record is -$1.84M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$7.00M | – |
| FY2025 | Mar 31, 2025 | -$7.65M | – |
| FY2024 | Mar 31, 2024 | -$10.13M | – |
| FY2023 | Mar 31, 2023 | -$10.51M | – |
| FY2022 | Mar 31, 2022 | -$9.77M | – |
| FY2021 | Mar 31, 2021 | -$6.76M | – |
| FY2020 | Mar 31, 2020 | -$5.20M | – |
| FY2019 | Mar 31, 2019 | -$4.29M | – |
| FY2018 | Mar 31, 2018 | -$3.91M | – |
| FY2017 | Mar 31, 2017 | -$3.51M | – |
| FY2016 | Mar 31, 2016 | -$4.33M | – |
| FY2015 | Mar 31, 2015 | -$5.05M | – |
| FY2014 | Mar 31, 2014 | -$2.14M | – |
| FY2013 | Mar 31, 2013 | -$2.10M | – |
| FY2012 | Mar 31, 2012 | -$1.84M | – |
| FY2011 | Mar 31, 2011 | -$1.97M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$1.90M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$1.75M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$1.71M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$1.67M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$2.01M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$2.21M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.75M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$2.57M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$2.38M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$2.70M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$2.48M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$2.95M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$1.95M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$2.88M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$2.73M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$3.10M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$2.72M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.88M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$2.07M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$2.24M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$2.20M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$1.23M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$1.10M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$1.62M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$1.26M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$1.07M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$1.25M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.40M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$1.09M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$991.27K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$818.43K | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$1.02M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$789.67K | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$1.03M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$1.07M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$953.97K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$788.24K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | -$935.76K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$827.93K | – |
See a number that looks wrong?